The role of vascular endothelial growth factor in restenosis: the controversy continues

Circulation. 2004 Oct 19;110(16):2283-6. doi: 10.1161/01.CIR.0000146723.23523.47.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adenoviridae / genetics
  • Angiogenesis Inducing Agents / adverse effects*
  • Angiogenesis Inducing Agents / therapeutic use
  • Animals
  • Catheterization / adverse effects
  • Coronary Restenosis / chemically induced*
  • Coronary Restenosis / etiology
  • Coronary Vessels / injuries
  • Genetic Therapy / adverse effects
  • Genetic Vectors / therapeutic use
  • Humans
  • Hyperplasia
  • Mice
  • Mice, Knockout
  • Rats
  • Receptors, Vascular Endothelial Growth Factor / classification
  • Receptors, Vascular Endothelial Growth Factor / drug effects
  • Receptors, Vascular Endothelial Growth Factor / genetics
  • Receptors, Vascular Endothelial Growth Factor / physiology
  • Receptors, Vascular Endothelial Growth Factor / therapeutic use
  • Recombinant Fusion Proteins / pharmacology
  • Recombinant Fusion Proteins / therapeutic use
  • Tunica Intima / drug effects*
  • Tunica Intima / pathology
  • Vascular Endothelial Growth Factor A / adverse effects*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / physiology
  • Vascular Endothelial Growth Factor A / therapeutic use

Substances

  • Angiogenesis Inducing Agents
  • Recombinant Fusion Proteins
  • VEGF-Trap fusion protein, recombinant
  • Vascular Endothelial Growth Factor A
  • Receptors, Vascular Endothelial Growth Factor